BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32770650)

  • 1. Leukoencephalopathy in Al-Raqad syndrome: Expanding the clinical and neuroimaging features caused by a biallelic novel missense variant in DCPS.
    Masoudi M; Bereshneh AH; Rasoulinezhad M; Ashrafi MR; Garshasbi M; Tavasoli AR
    Am J Med Genet A; 2020 Oct; 182(10):2391-2398. PubMed ID: 32770650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An additional patient with a homozygous mutation in DCPS contributes to the delination of Al-Raqad syndrome.
    Alesi V; Capolino R; Genovesea S; Capriati T; Loddo S; Calvieri G; Calacci C; Diociaiuti A; Diamanti A; Novelli A; Dallapiccola B
    Am J Med Genet A; 2018 Dec; 176(12):2781-2786. PubMed ID: 30289615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the scavenger mRNA decapping enzyme DCPS causes syndromic intellectual disability with neuromuscular defects.
    Ng CK; Shboul M; Taverniti V; Bonnard C; Lee H; Eskin A; Nelson SF; Al-Raqad M; Altawalbeh S; Séraphin B; Reversade B
    Hum Mol Genet; 2015 Jun; 24(11):3163-71. PubMed ID: 25712129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebellofaciodental syndrome in an adult patient: Expanding the phenotypic and natural history characteristics.
    Honjo RS; Castro MAA; Ferraciolli SF; Soares Junior LAV; Pastorino AC; Bertola DR; Miyake N; Matsumoto N; Kim CA
    Am J Med Genet A; 2021 May; 185(5):1561-1568. PubMed ID: 33645901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in DCPS and EDC3 in autosomal recessive intellectual disability indicate a crucial role for mRNA decapping in neurodevelopment.
    Ahmed I; Buchert R; Zhou M; Jiao X; Mittal K; Sheikh TI; Scheller U; Vasli N; Rafiq MA; Brohi MQ; Mikhailov A; Ayaz M; Bhatti A; Sticht H; Nasr T; Carter MT; Uebe S; Reis A; Ayub M; John P; Kiledjian M; Vincent JB; Jamra RA
    Hum Mol Genet; 2015 Jun; 24(11):3172-80. PubMed ID: 25701870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WDR73 missense mutation causes infantile onset intellectual disability and cerebellar hypoplasia in a consanguineous family.
    Jiang C; Gai N; Zou Y; Zheng Y; Ma R; Wei X; Liang D; Wu L
    Clin Chim Acta; 2017 Jan; 464():24-29. PubMed ID: 27983999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the phenotype of cerebellar-facial-dental syndrome: Two siblings with a novel variant in BRF1.
    Valenzuela I; Codina M; Fernández-Álvarez P; Mur P; Valle L; Tizzano EF; Cuscó I
    Am J Med Genet A; 2020 Nov; 182(11):2742-2745. PubMed ID: 32896090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missense variant in CCDC22 causes X-linked recessive intellectual disability with features of Ritscher-Schinzel/3C syndrome.
    Kolanczyk M; Krawitz P; Hecht J; Hupalowska A; Miaczynska M; Marschner K; Schlack C; Emmerich D; Kobus K; Kornak U; Robinson PN; Plecko B; Grangl G; Uhrig S; Mundlos S; Horn D
    Eur J Hum Genet; 2015 May; 23(5):633-8. PubMed ID: 24916641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel ANKRD11 gene mutation in an individual with a mild phenotype of KBG syndrome associated to a GEFS+ phenotypic spectrum: a case report.
    Alves RM; Uva P; Veiga MF; Oppo M; Zschaber FCR; Porcu G; Porto HP; Persico I; Onano S; Cuccuru G; Atzeni R; Vieira LCN; Pires MVA; Cucca F; Toralles MBP; Angius A; Crisponi L
    BMC Med Genet; 2019 Jan; 20(1):16. PubMed ID: 30642272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MED12 missense mutation in a three-generation family. Clinical characterization of MED12-related disorders and literature review.
    Rubinato E; Rondeau S; Giuliano F; Kossorotoff M; Parodi M; Gherbi S; Steffan J; Jonard L; Marlin S
    Eur J Med Genet; 2020 Mar; 63(3):103768. PubMed ID: 31536828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMC10 homozygous variant identified in a family with global developmental delay, mild intellectual disability, and speech delay.
    Umair M; Ballow M; Asiri A; Alyafee Y; Al Tuwaijri A; Alhamoudi KM; Aloraini T; Abdelhakim M; Althagafi AT; Kafkas S; Alsubaie L; Alrifai MT; Hoehndorf R; Alfares A; Alfadhel M
    Clin Genet; 2020 Dec; 98(6):555-561. PubMed ID: 32869858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation in GMPPA in siblings with apparent intellectual disability, epilepsy, dysmorphism, and autonomic dysfunction.
    Gold WA; Sobreira N; Wiame E; Marbaix A; Van Schaftingen E; Franzka P; Riley LG; Worgan L; Hübner CA; Christodoulou J; Adès LC
    Am J Med Genet A; 2017 Aug; 173(8):2246-2250. PubMed ID: 28574218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel patient with White-Sutton syndrome refines the mutational and clinical repertoire of the POGZ-related phenotype and suggests further observations.
    Pascolini G; Agolini E; Fleischer N; Gulotta E; Cesario C; D'Elia G; Novelli A; Majore S; Grammatico P
    Am J Med Genet A; 2020 Jul; 182(7):1791-1795. PubMed ID: 32359026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous GRID2 missense mutation predicts a shift in the D-serine binding domain of GluD2 in a case with generalized brain atrophy and unusual clinical features.
    Ali Z; Zulfiqar S; Klar J; Wikström J; Ullah F; Khan A; Abdullah U; Baig S; Dahl N
    BMC Med Genet; 2017 Dec; 18(1):144. PubMed ID: 29207948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic sequence variants in INTS1 in patients with developmental delays, cataracts, and craniofacial anomalies.
    Krall M; Htun S; Schnur RE; Brooks AS; Baker L; de Alba Campomanes A; Lamont RE; Gripp KW; ; Schneidman-Duhovny D; Innes AM; Mancini GMS; Slavotinek AM
    Eur J Hum Genet; 2019 Apr; 27(4):582-593. PubMed ID: 30622326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel pathogenic variant in the 3' end of the AGTPBP1 gene gives rise to neurodegeneration without cerebellar atrophy: an expansion of the disease phenotype?
    Türay S; Eröz R; Başak AN
    Neurogenetics; 2021 May; 22(2):127-132. PubMed ID: 33909173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brother and sister with intellectual disability and characteristic neuroimaging findings.
    Hermens M; van der Knaap MS; Kamsteeg EJ; Willemsen MA
    Eur J Paediatr Neurol; 2018 Sep; 22(5):866-869. PubMed ID: 29970281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further delineation of Malan syndrome.
    Priolo M; Schanze D; Tatton-Brown K; Mulder PA; Tenorio J; Kooblall K; Acero IH; Alkuraya FS; Arias P; Bernardini L; Bijlsma EK; Cole T; Coubes C; Dapia I; Davies S; Di Donato N; Elcioglu NH; Fahrner JA; Foster A; González NG; Huber I; Iascone M; Kaiser AS; Kamath A; Liebelt J; Lynch SA; Maas SM; Mammì C; Mathijssen IB; McKee S; Menke LA; Mirzaa GM; Montgomery T; Neubauer D; Neumann TE; Pintomalli L; Pisanti MA; Plomp AS; Price S; Salter C; Santos-Simarro F; Sarda P; Segovia M; Shaw-Smith C; Smithson S; Suri M; Valdez RM; Van Haeringen A; Van Hagen JM; Zollino M; Lapunzina P; Thakker RV; Zenker M; Hennekam RC
    Hum Mutat; 2018 Sep; 39(9):1226-1237. PubMed ID: 29897170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel compound heterozygous mutations in GPT2 linked to microcephaly, and intellectual developmental disability with or without spastic paraplegia.
    Kaymakcalan H; Yarman Y; Goc N; Toy F; Meral C; Ercan-Sencicek AG; Gunel M
    Am J Med Genet A; 2018 Feb; 176(2):421-425. PubMed ID: 29226631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing reveals a novel CWF19L1 mutation associated with intellectual disability and cerebellar atrophy.
    Evers C; Kaufmann L; Seitz A; Paramasivam N; Granzow M; Karch S; Fischer C; Hinderhofer K; Gdynia G; Elsässer M; Pinkert S; Schlesner M; Bartram CR; Moog U
    Am J Med Genet A; 2016 Jun; 170(6):1502-9. PubMed ID: 27016154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.